Form: 10-K

Annual report pursuant to Section 13 and 15(d)

October 29, 1996

EXHIBIT 11

Published on October 29, 1996



EXHIBIT 11


ENZO BIOCHEM, INC.
COMPUTATION OF PER-SHARE EARNINGS
Years ended July 31, 1996, 1995 and 1994



1996* 1995* 1994*
----- ----- -----
Primary
Average shares outstanding 22,593,000 22,005,200 21,469,200

Net effect of dilutive stock options and
warrants -- based on the treasury stock
method using average market price -- 1,069,900 1,158,400
----------- ----------- -----------

Total 22,593,000 23,075,100 22,627,600
----------- ----------- -----------
----------- ----------- -----------

Income (loss) before extraordinary items $(7,707,500) $ 5,618,100 $ 5,101,200
Extraordinary gain -- -- 150,000
----------- ----------- -----------
Net income (loss) $(7,707,500) $ 5,618,100 $ 5,251,200
----------- ----------- -----------
----------- ----------- -----------

Per common and common equivalent share
Income (loss) before extraordinary item ($.34) $.24 $.22
Extraordinary gain -- -- .01
----- ----- -----
Net income (loss) ($.34) $.24 $.23
----- ----- -----
----- ----- -----


*Shares and per share amounts have been adjusted for the 5% stock dividend
declared in fiscal 1995 and for the 5% stock dividend declared in September
1996.






E-25